Publication

Assessing the Hemodynamic Impact of Anterior Leaflet Laceration in Transcatheter Mitral Valve Replacement: An in silico Study

Downloadable Content

Persistent URL
Last modified
  • 05/23/2025
Type of Material
Authors
    Keshav Kohli, Georgia Institute of TechnologyZhenglun A Wei, Georgia Institute of TechnologyVahid Sadri, Georgia Institute of TechnologyAndrew W Siefert, Georgia Institute of TechnologyPhilipp Blanke, University of British ColumbiaEmily Perdoncin, Emory University HospitalAdam Greenbaum, Emory UniversityJaffar M Khan, National Heart Lung and Blood Institute, National Institutes of Health, BethesdaRobert Lederman, Emory UniversityVasilis Babaliaros, Emory UniversityAjit Yoganathan, Emory UniversityJohn Oshinski, Emory University
Language
  • English
Date
  • 2022-06-09
Publisher
  • FRONTIERS MEDIA SA
Publication Version
Copyright Statement
  • © 2022 Kohli, Wei, Sadri, Siefert, Blanke, Perdoncin, Greenbaum, Khan, Lederman, Babaliaros, Yoganathan and Oshinski.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 9
Start Page
  • 869259
End Page
  • 869259
Grant/Funding Information
  • This study was supported by American Heart Association Pre-doctoral Fellowship 20PRE35200392 (Kohli) and National Institutes of Health (NIH) grant R01EB027774 (Oshinski).
Supplemental Material (URL)
Abstract
  • Background: A clinical study comparing the hemodynamic outcomes of transcatheter mitral valve replacement (TMVR) with vs. without Laceration of the Anterior Mitral leaflet to Prevent Outflow Obstruction (LAMPOON) has never been designed nor conducted. Aims: To quantify the hemodynamic impact of LAMPOON in TMVR using patient-specific computational (in silico) models. Materials: Eight subjects from the LAMPOON investigational device exemption trial were included who had acceptable computed tomography (CT) data for analysis. All subjects were anticipated to be at prohibitive risk of left ventricular outflow tract (LVOT) obstruction from TMVR, and underwent successful LAMPOON immediately followed by TMVR. Using post-procedure CT scans, two 3D anatomical models were created for each subject: (1) TMVR with LAMPOON (performed procedure), and (2) TMVR without LAMPOON (virtual control). A validated computational fluid dynamics (CFD) paradigm was then used to simulate the hemodynamic outcomes for each condition. Results: LAMPOON exposed on average 2 ± 0.6 transcatheter valve cells (70 ± 20 mm2 total increase in outflow area) which provided an additional pathway for flow into the LVOT. As compared to TMVR without LAMPOON, TMVR with LAMPOON resulted in lower peak LVOT velocity, lower peak LVOT gradient, and higher peak LVOT effective orifice area by 0.4 ± 0.3 m/s (14 ± 7% improvement, p = 0.006), 7.6 ± 10.9 mmHg (31 ± 17% improvement, p = 0.01), and 0.2 ± 0.1 cm2 (17 ± 9% improvement, p = 0.002), respectively. Conclusion: This was the first study to permit a quantitative, patient-specific comparison of LVOT hemodynamics following TMVR with and without LAMPOON. The LAMPOON procedure achieved a critical increment in outflow area which was effective for improving LVOT hemodynamics, particularly for subjects with a small neo-left ventricular outflow tract (neo-LVOT).
Author Notes
Keywords
Research Categories
  • Health Sciences, Radiology
  • Engineering, Biomedical

Tools

Relations

In Collection:

Items